|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04.11.25 - 13:06
|
Orthofix Reports Third Quarter 2025 Financial Results (Business Wire)
|
|
|
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the third quarter ended September 30, 2025, narrowed its full-year 2025 net sales guidance while maintaining the midpoint, and raised the low end of its adjusted EBITDA guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6™ product lines.
Highlights
Third quarter 2025 net sales of $205.6 million, including sales from M6 artificial cervical and lumbar discs, and pro forma net sales of $203.4 million, excluding sales from M6 discs, representing an increase of 5% on a reported basis and 6% on a pro forma constant currency basis compared to third quarter 2024
U.S. Spine Fixation1 net sales growth of 8% and procedure volume growth of 10% compared to third quarter 2024
Bone Growth Therapies net sales of $61.2 million, representing growth of 6% compared to third quarter 2024
Glo...
|
|
|
14.10.25 - 13:03
|
Orthofix to Report Third Quarter 2025 Financial Results (Business Wire)
|
|
|
Company to Host Conference Call on Tuesday, November 4, 2025, at 8:30 am Eastern TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.
Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 5112586. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.
Internet Posting of Information
Orthofix regularly shares important updates in the “Investors” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.
About Orthofix
Orthofix is ...
|
|
|
|
|
|
|
|
|
|
|
05.08.25 - 13:06
|
Orthofix Reports Second Quarter 2025 Financial Results (Business Wire)
|
|
|
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2025, and reaffirmed its full-year 2025 financial guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6® product lines.
Highlights
Second quarter 2025 net sales of $203.1 million, including sales from M6® artificial cervical and lumbar discs, and pro forma net sales of $200.7 million, excluding sales from M6® discs, representing an increase of 2% on a reported basis and 4% on a pro forma constant currency basis compared to second quarter 2024
U.S. Spine Fixation1 net sales growth of 5% and procedure volume growth of 7% compared to second quarter 2024
Bone Growth Therapies ("BGT") net sales of $62.6 million, representing growth of 6%, with BGT Fracture net sales growth of 7% compared to second quarter 2024
Global Orthopedics net...
|
|
|
15.07.25 - 13:06
|
Orthofix to Report Second Quarter 2025 Financial Results (Business Wire)
|
|
|
Company to Host Conference Call on Tuesday, August 5, 2025 at 8:30 am Eastern TimeLEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.
Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 4830464. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.
Internet Posting of Information
Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com. Orthofix encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix...
|
|
|
|
|
|
|
|
|
|
|
|
|
|